Flecainide

Contraindicated

Flecainide Bepridil An increased risk of QT interval prolongation Details Flecainide Cisapride Propulsid® Increased risk of QT interval prolongation Details Flecainide Dronedarone Multaq Increased risk of QT interval prolongation Details Flecainide Levoketoconazole Recorlev An increased risk of QT interval prolongation, an increased risk of serious hepatotoxicity and drug-induced liver injury Details Flecainide Levomethadyl An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Flecainide Mavorixafor Xolremdi Increased CYP2D6 substrate exposure, increased risk of CYP2D6-related adverse events and an increased risk of QT interval prolonga... Details Flecainide Mesoridazine An increased risk of QT interval prolongation Details Flecainide Nirmatrelvir Increased flecainide plasma concentrations; potential for arrhythmias Details Flecainide Pimozide An increased risk of QT interval prolongation Details Flecainide Piperaquine An increased risk of QT interval prolongation Details Flecainide Ritonavir Norvir Increased flecainide exposure and an increased risk of cardiac arrhythmias Details Flecainide Saquinavir Increased flecainide plasma concentrations and increased risk for serious cardiac arrhythmia Details Flecainide Sparfloxacin An increased risk of QT interval prolongation Details Flecainide Terfenadine An increased risk of QT interval prolongation Details Flecainide Thioridazine An increased risk of QT interval prolongation Details Flecainide Tipranavir Aptivus An increased risk of flecainide toxicity including life-threatening cardiac arrhythmias Details Flecainide Vernakalant Increased risk of atrial flutter and other cardiovascular events Details Flecainide Ziprasidone Geodon An increased risk of QT interval prolongation Details

Major

Flecainide Amitriptyline Elavil An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Flecainide Sertraline An increased risk of QT interval prolongation, an increased flecainide exposure and risk for toxicity (cardiac arrhythmia) Details Flecainide Buprenorphine Belbuca An increased risk of QT interval prolongation Details Flecainide Relugolix Orgovyx Increased risk of QT interval prolongation Details Flecainide Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Flecainide Arsenic Trioxide Trisenox An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Flecainide Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Flecainide Arsenic Trioxide Injection Trisenox An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Flecainide Asenapine Transdermal Patch Secuado Increased flecainide exposure, an increased asenapine exposure, an increased risk of QT interval prolongation and an increased ris... Details Flecainide Azathioprine Azasan An increased risk of hepatotoxicity Details Flecainide Azithromycin AzaSite An increased risk of QT interval prolongation Details Flecainide Abiraterone Abirtega Increased CYP2D6 substrate exposure and an increased risk of CYP2D6 substrate-related adverse effects Details Flecainide Alfuzosin UroXatral An increased risk of QT interval prolongation Details Flecainide Anagrelide Agrylin Increased risk of QT interval prolongation Details Flecainide Bedaquiline Sirturo Increased risk of QT interval prolongation Details Flecainide Chloroquine Aralen® An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Flecainide Dacomitinib Vizimpro Increased exposure of the CYP2D6 substrate Details Flecainide Dasatinib Phyrago An increased risk of QT interval prolongation Details Flecainide Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Flecainide Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Flecainide Disopyramide Norpace An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Flecainide Dofetilide Tikosyn An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details